Position in PSNL
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,202,600
+$1,680,170 QoQ
Shares Held
239,000
0.0% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
2.53%
of 13F equity value
Holder Rank
#2
of 13 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in PSNL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PERKINS CAPITAL MANAGEMENT INC holds $26,693,573 across 9 Diagnostics & Research names. PSNL ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
40,605 | $11,022,227 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
9,700 | $5,106,468 | |
| 3 | VCYT |
Veracyte, Inc.
|
59,958 | $3,521,333 | |
| 4 | PSNL |
Personalis, Inc.
This page
|
239,000 | $3,202,600 | |
| 5 | NEO |
Neogenomics Inc
|
110,040 | $1,605,483 | |
| 6 | BDSX |
Biodesix Inc
|
44,618 | $1,006,135 | |
| 7 | MDXH |
MDxHealth SA
|
1,411,891 | $580,287 | |
| 8 | CSTL |
Castle Biosciences Inc
|
16,140 | $384,939 |
All Filings in PSNL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,202,600 | 239,000 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,522,430 | 239,000 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,902,440 | 239,000 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,646,300 | 252,500 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,656,400 | 252,500 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $903,147 | 257,307 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,487,234 | 257,307 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,384,311 | 257,307 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $301,049 | 257,307 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||